The results showed that immunoregulatory interactions between lymphoid and nonlymphoid cells, the internal immune network for IgA production, autoimmune thyroid disease, primary immunodeficiencies, and cancer immunotherapy by PD-1 blockade were differentially enriched due to CNPY4 overexpression. Here, CD79A is linked to cancer.